Raymond Woo, Chief Technology Officer of Ceribell, Inc. (NASDAQ:CBLL), filed a Form 4 on November 4, 2026, disclosing option exercises and a sale of common stock executed on November 2, 2026, under a Rule 10b5-1 trading plan.
Key Highlights
- Sale of 4,887 shares: Raymond Woo disposed of 4,887 shares of common stock at $26.96 per share on November 2, 2026.
- Option exercise (first tranche): Woo exercised a stock option covering 4,864 shares at an exercise price of $3.65, reducing the remaining option to 43,773 shares.
- Option exercise (second tranche): Woo exercised a stock option covering 23 shares at an exercise price of $4.70, reducing that remaining option to 18,998 shares.
- Post-transaction ownership: Following the reported transactions, Woo directly held 203,118 shares of common stock.
- 10b5-1 plan: According to the filing, all transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Woo on June 5, 2026.
- Both options fully vested: The filing states both stock options exercised are "fully vested and currently exercisable."
Raymond Woo's November 2026 Option Exercises and Share Sale at Ceribell
According to the Form 4 filed with the SEC on November 4, 2026, Raymond Woo, the Chief Technology Officer of Ceribell, Inc. (NASDAQ:CBLL), executed three transactions on November 2, 2026. The filing indicates that Woo first acquired 4,864 shares of common stock through the exercise of a stock option with an exercise price of $3.65 per share, and separately acquired 23 shares through the exercise of a second stock option with an exercise price of $4.70 per share. Following those exercises, Woo disposed of a combined total of 4,887 shares of common stock at a price of $26.96 per share.
The filing discloses that the stock option with an exercise price of $3.65 carries an expiration date of June 10, 2031, while the option with an exercise price of $4.70 expires on February 16, 2033. After the reported transactions, the remaining balances on those options stand at 43,773 shares and 18,998 shares, respectively, according to the filing. Both options are described in the filing as "fully vested and currently exercisable," with a reported price of $0 for each derivative transaction.
The filing states that all three transactions "were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026." The Form 4 was signed by Jessica Puathasnanon as Attorney-in-Fact for Raymond Woo. After all reported activity, Woo's direct beneficial ownership of Ceribell common stock stood at 203,118 shares, as reported in the filing.
What Was Disclosed
Ceribell CTO Raymond Woo filed a Form 4 reporting the exercise of two stock options totaling 4,887 shares and an equal same-day sale at $26.96 per share on November 2, 2026, pursuant to a pre-established 10b5-1 trading plan adopted June 5, 2026.



Please wait processing your request...